NON-ST ELEVATION MYOCARDIAL INFARCTION
Clinical trials for NON-ST ELEVATION MYOCARDIAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new NON-ST ELEVATION MYOCARDIAL INFARCTION trials appear
Sign up with your email to follow new studies for NON-ST ELEVATION MYOCARDIAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug trial halted after only 6 patients
Disease control TerminatedThis trial tested a new drug called MT1002 in 6 people having a heart procedure (PCI) after a heart attack. The goal was to see if it could safely control blood clotting. However, the study was stopped early, so we don't have enough information to know if the drug works or is saf…
Matched conditions: NON-ST ELEVATION MYOCARDIAL INFARCTION
Phase: PHASE2 • Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
One shot may replace hours of infusion for heart attack care
Disease control TerminatedThis study tested whether a single dose of the drug abciximab given directly into the heart artery works as well as the standard approach of a dose into a vein followed by a 12-hour infusion. The goal was to reduce heart muscle damage in people having their first non-ST elevation…
Matched conditions: NON-ST ELEVATION MYOCARDIAL INFARCTION
Phase: PHASE4 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC